TG Therapeutics's total assets for Q3 2025 were $1.03B, an increase of 45.89% from the previous quarter. TGTX total liabilities were $417.81M for the fiscal quarter, a -1.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.